410 related articles for article (PubMed ID: 31055911)
1. Self-Strengthened Oxidation-Responsive Bioactivating Prodrug Nanosystem with Sequential and Synergistically Facilitated Drug Release for Treatment of Breast Cancer.
Wang K; Yang B; Ye H; Zhang X; Song H; Wang X; Li N; Wei L; Wang Y; Zhang H; Kan Q; He Z; Wang D; Sun J
ACS Appl Mater Interfaces; 2019 May; 11(21):18914-18922. PubMed ID: 31055911
[TBL] [Abstract][Full Text] [Related]
2. Vitamin E-based redox-sensitive salinomycin prodrug-nanosystem with paclitaxel loaded for cancer targeted and combined chemotherapy.
Liang DS; Liu J; Peng TX; Peng H; Guo F; Zhong HJ
Colloids Surf B Biointerfaces; 2018 Dec; 172():506-516. PubMed ID: 30212688
[TBL] [Abstract][Full Text] [Related]
3. A pH-Responsive Charge-Reversal Drug Delivery System with Tumor-Specific Drug Release and ROS Generation for Cancer Therapy.
Xu C; Song R; Lu P; Chen J; Zhou Y; Shen G; Jiang M; Zhang W
Int J Nanomedicine; 2020; 15():65-80. PubMed ID: 32021165
[TBL] [Abstract][Full Text] [Related]
4. In vivo tailor-made protein corona of a prodrug-based nanoassembly fabricated by redox dual-sensitive paclitaxel prodrug for the superselective treatment of breast cancer.
Zhang D; Yang J; Guan J; Yang B; Zhang S; Sun M; Yang R; Zhang T; Zhang R; Kan Q; Zhang H; He Z; Shang L; Sun J
Biomater Sci; 2018 Aug; 6(9):2360-2374. PubMed ID: 30019051
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy.
Sun B; Chen Y; Yu H; Wang C; Zhang X; Zhao H; Chen Q; He Z; Luo C; Sun J
Acta Biomater; 2019 Jul; 92():219-228. PubMed ID: 31078764
[TBL] [Abstract][Full Text] [Related]
6. Integrated block copolymer prodrug nanoparticles for combination of tumor oxidative stress amplification and ROS-responsive drug release.
Yin W; Ke W; Chen W; Xi L; Zhou Q; Mukerabigwi JF; Ge Z
Biomaterials; 2019 Mar; 195():63-74. PubMed ID: 30612064
[TBL] [Abstract][Full Text] [Related]
7. An exosome-like programmable-bioactivating paclitaxel prodrug nanoplatform for enhanced breast cancer metastasis inhibition.
Wang K; Ye H; Zhang X; Wang X; Yang B; Luo C; Zhao Z; Zhao J; Lu Q; Zhang H; Kan Q; Wang Y; He Z; Sun J
Biomaterials; 2020 Oct; 257():120224. PubMed ID: 32736255
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo.
Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R
Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390
[TBL] [Abstract][Full Text] [Related]
9. Zein-Paclitaxel Prodrug Nanoparticles for Redox-Triggered Drug Delivery and Enhanced Therapeutic Efficiency.
Hou H; Zhang D; Lin J; Zhang Y; Li C; Wang Z; Ren J; Yao M; Wong KH; Wang Y
J Agric Food Chem; 2018 Nov; 66(44):11812-11822. PubMed ID: 30339011
[TBL] [Abstract][Full Text] [Related]
10. Self-Assembled Redox Dual-Responsive Prodrug-Nanosystem Formed by Single Thioether-Bridged Paclitaxel-Fatty Acid Conjugate for Cancer Chemotherapy.
Luo C; Sun J; Liu D; Sun B; Miao L; Musetti S; Li J; Han X; Du Y; Li L; Huang L; He Z
Nano Lett; 2016 Sep; 16(9):5401-8. PubMed ID: 27490088
[TBL] [Abstract][Full Text] [Related]
11. Light-activatable dual-source ROS-responsive prodrug nanoplatform for synergistic chemo-photodynamic therapy.
Yang B; Wang K; Zhang D; Sun B; Ji B; Wei L; Li Z; Wang M; Zhang X; Zhang H; Kan Q; Luo C; Wang Y; He Z; Sun J
Biomater Sci; 2018 Nov; 6(11):2965-2975. PubMed ID: 30255178
[TBL] [Abstract][Full Text] [Related]
12. A tumor-specific ROS self-supply enhanced cascade-responsive prodrug activation nanosystem for amplified chemotherapy against multidrug-resistant tumors.
Wang J; Zhang H; Lv J; Zheng Y; Li M; Yang G; Wei X; Li N; Huang H; Li T; Qin X; Li S; Wu C; Zhang W; Liu Y; Yang H
Acta Biomater; 2023 Jul; 164():522-537. PubMed ID: 37072069
[TBL] [Abstract][Full Text] [Related]
13. Co-Delivery of Paclitaxel and Doxorubicin by pH-Responsive Prodrug Micelles for Cancer Therapy.
Jiang Y; Zhou Y; Zhang CY; Fang T
Int J Nanomedicine; 2020; 15():3319-3331. PubMed ID: 32494132
[TBL] [Abstract][Full Text] [Related]
14. Precisely albumin-hitchhiking tumor cell-activated reduction/oxidation-responsive docetaxel prodrugs for the hyperselective treatment of breast cancer.
Wei W; Luo C; Yang J; Sun B; Zhao D; Liu Y; Wang Y; Yang W; Kan Q; Sun J; He Z
J Control Release; 2018 Sep; 285():187-199. PubMed ID: 30017721
[TBL] [Abstract][Full Text] [Related]
15. Co-Delivery of Paclitaxel by a Capsaicin Prodrug Micelle Facilitating for Combination Therapy on Breast Cancer.
Lan Y; Sun Y; Yang T; Ma X; Cao M; Liu L; Yu S; Cao A; Liu Y
Mol Pharm; 2019 Aug; 16(8):3430-3440. PubMed ID: 31199661
[TBL] [Abstract][Full Text] [Related]
16. Photosensitizer-driven nanoassemblies of homodimeric prodrug for self-enhancing activation and synergistic chemo-photodynamic therapy.
Zhang S; Wang Z; Kong Z; Wang Y; Zhang X; Sun B; Zhang H; Kan Q; He Z; Luo C; Sun J
Theranostics; 2021; 11(12):6019-6032. PubMed ID: 33897896
[TBL] [Abstract][Full Text] [Related]
17. ROS-Activated homodimeric podophyllotoxin nanomedicine with self-accelerating drug release for efficient cancer eradication.
Liang B; Zhou D
Drug Deliv; 2021 Dec; 28(1):2361-2372. PubMed ID: 34747277
[TBL] [Abstract][Full Text] [Related]
18. A pH/ROS cascade-responsive and self-accelerating drug release nanosystem for the targeted treatment of multi-drug-resistant colon cancer.
Chang N; Zhao Y; Ge N; Qian L
Drug Deliv; 2020 Dec; 27(1):1073-1086. PubMed ID: 32706272
[TBL] [Abstract][Full Text] [Related]
19. Selective self-induced stimulus amplification prodrug platform for inhibiting multidrug resistance and lung metastasis.
Xu C; Sun Y; Qi Y; Yu Y; He Y; Hu M; Hu Q; Wu T; Zhang D; Shang L; Deng H; Zhang Z
J Control Release; 2018 Aug; 284():224-239. PubMed ID: 29958912
[TBL] [Abstract][Full Text] [Related]
20. Development of redox-responsive theranostic nanoparticles for near-infrared fluorescence imaging-guided photodynamic/chemotherapy of tumor.
Yang X; Shi X; Ji J; Zhai G
Drug Deliv; 2018 Nov; 25(1):780-796. PubMed ID: 29542333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
